ProPhotonix Limited New Hyperspectral COBRA MultiSpec LED Line Light
26 Janvier 2021 - 8:00AM
RNS Non-Regulatory
TIDMPPIX
ProPhotonix Limited
26 January 2021
January 26, 2021
ProPhotonix Limited
("ProPhotonix" or "the Company")
ProPhotonix Launches New Hyperspectral COBRA(TM) MultiSpec LED
Line Lights
New high-performance hyperspectral light source with a spectral
range from 400 - 1000nm
ProPhotonix Limited, (London Stock Exchange - AIM: PPIX; OTC:
STKR), a designer and manufacturer of LED illumination systems and
laser diode modules with operations in Ireland and the United
Kingdom, is pleased to announce the addition of a new hyperspectral
LED line light to its COBRA(TM) MultiSpec platform. With a spectral
range from 400-1000nm and excellent spatial and spectral
uniformity, this new option provides an excellent solution for
hyperspectral applications.
Successful hyperspectral imaging requires careful wavelength
selection to cover the required spectrum and homogenous light to
ensure high quality imaging. ProPhotonix has developed this
hyperspectral line light as an ideal light source for any
hyperspectral line scan camera operating in the visible to
near-infrared spectrum. The spectrum is well-matched to the highly
compact and flexible Specim FX10, for example, or machine vision
cameras utilizing the latest SONY IMX174 Sensor. For applications
covering an extended spectrum, the COBRA MultiSpec can be developed
in configurations of up to twelve wavelengths from 365nm
-1700nm.
The new COBRA MultiSpec option offers an ideal solution for
hyperspectral applications including currency inspection,
pharmaceutical analysis, food sorting, grading and analysis,
recycling and print inspection.
Adoption of LED technology for hyperspectral imaging
applications is rapidly increasing. LEDs offer significant
advantages over traditional halogen light sources including
compactness, longer lifetimes and greater control of the emission
spectrum. System designers will benefit from reduced form factors,
without the need for additional heat extraction equipment, longer
lifetimes, and excellent spectral control allowing improved system
optimization and enabling new applications.
First launched in 2017, the award-winning COBRA MultiSpec is
designed to deliver tunable, multispectral illumination allowing
users to optimize the spectrum and contrast in their application.
The new user-friendly GUI provides precise control of the light
allowing system designers to easily fine tune the performance of
the system. Discrete control of each wavelength allows users to
configure the optimum wavelength balancing and relative intensities
to refine the output spectrum specific to the application needs.
The platform operates in both continuous and strobe mode with
exceptional strobe capability enabling high speed image
acquisition.
Simon Stanley, Director of Technology at ProPhotonix (IRL), said
"We are pleased to offer this new hyperspectral option of our COBRA
MultiSpec platform. Hyperspectral imaging is advancing rapidly and
this product launch enables our customers to access the latest in
LED technology. Customers can work with our expert engineering team
to select the exact spectrum. Users can further optimize for the
application via the user-friendly GUI. Custom configurations can be
developed for virtually any hyperspectral application."
For more information, visit :
https://www2.prophotonix.com/Hyperspectral-LED-Line-Light
Contact:
ProPhotonix Limited Tel: +353(0) 21 5001313
Simon Stanley, Director of Technology, sales@prophotonix.com
ProPhotonix
WH Ireland Limited
Katy Mitchell Nominated Adviser and Broker
Matthew Chan Tel: +44 (0) 20 7220 1666
About ProPhotonix
ProPhotonix Limited, headquartered in Salem, New Hampshire, is a
high technology designer and manufacturer of diode-based laser
modules and LED systems for industry leading OEMs and medical
equipment companies. In addition, the Company distributes premium
diodes for Ushio, Osram, QSI, Panasonic, and Sony. The Company
serves a wide range of markets including the machine vision,
industrial inspection, security, and medical markets. ProPhotonix
has offices and subsidiaries in the U.S., Ireland, U.K., and
Europe. For more information about ProPhotonix and its innovative
products, visit the Company's web site at www.prophotonix.com .
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAMZGZMZKLGMZM
(END) Dow Jones Newswires
January 26, 2021 02:00 ET (07:00 GMT)
Prophotonix (LSE:PPIX)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Prophotonix (LSE:PPIX)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024